QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Boullerne, A. I. Articles by Petry, K. G. Search for Related Content PubMed PubMed Citation Articles by Boullerne, A. I. Articles by Petry, K. G.

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 2002, 22(1):123-132

Anti-S-Nitrosocysteine Antibodies Are a Predictive Marker for Demyelination in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis

Anne I. Boullerne^{1, 3}, José J. Rodríguez², Tarik Touil³, Bruno Brochet³, Stephan Schmidt⁴, Nora D. Abrous², Michel Le Moal², Jeffrey R. Pua¹, Mark A. Jensen¹, Willy Mayo², Barry G. W. Arnason¹, and Klaus G. Petry³

¹ Department of Neurology, University of Chicago, Chicago, Illinois 60637, ² Institut National de la Santé et de la Recherche Médicale, Unité 259, and ³ Laboratory of Neurobiologie des Affections de la Myéline EA2966, Victor Segalen Bordeaux II University, 33076 Bordeaux, France, and ⁴ Department of Neurology, University of Bonn, 53105 Bonn, Germany

Multiple sclerosis (MS) is characterized by inflammation within the CNS. This inflammatory response is associated with production of nitric oxide (NO) and NO-related species that nitrosylate thiols. We postulated that MS patients would exhibit an antibody (Ab) response directed against proteins containing S-nitrosocysteine (SNO-cysteine) and showed that anti-NO-cysteine Abs of the IgM isotype are in fact present in the sera of some MS patients (Boullerne et al., 1995). We report here the presence of a seemingly identical Ab response directed against SNO-cysteine in an acute model of MS, experimental autoimmune encephalomyelitis (EAE) induced in Lewis rats with the 68-84 peptide of guinea pig myelin basic protein (MBP_68-84). Serum levels of anti-SNO-cysteine Abs peaked 1 week before the onset of clinical signs and well before the appearance of anti-MBP_68-84 Abs. The anti-SNO-cysteine Ab peak titer correlated with the extent of subsequent CNS demyelination, suggesting a link between Ab level and CNS lesion formation. In relapsing-remitting MS patients, we found elevated anti-SNO-cysteine Ab at times of relapse and normal values in most patients judged to be in remission. Two-thirds of patients with secondary progressive MS had elevated anti-SNO-cysteine Ab levels, including those receiving interferon -1b. The data show that a rise in circulating anti-SNO-cysteine Ab levels precedes onset of EAE. Anti-SNO-cysteine Abs are also elevated at times of MS attacks and in progressive disease, suggesting a possible role for these Abs, measurable in blood, as a biological marker for clinical activity.

Key words: experimental autoimmune encephalomyelitis; multiple sclerosis; autoimmunity; nitric oxide; antibody; clinical marker

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/221123-10$05.00/0

This article has been cited by other articles:

				Y. Y. Tyurina, L. V. Basova, N. V. Konduru, V. A. Tyurin, A. I. Potapovich, P. Cai, H. Bayir, D. Stoyanovsky, B. R. Pitt, A. A. Shvedova, et al. Nitrosative Stress Inhibits the Aminophospholipid Translocase Resulting in Phosphatidylserine Externalization and Macrophage Engulfment: IMPLICATIONS FOR THE RESOLUTION OF INFLAMMATION J. Biol. Chem., March 16, 2007; 282(11): 8498 - 8509. [Abstract] [Full Text] [PDF]

				E. C. Jauch, C. Lindsell, J. Broderick, S. C. Fagan, B. C. Tilley, S. R. Levine, and for the NINDS rt-PA Stroke Study Group Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Stroke, October 1, 2006; 37(10): 2508 - 2513. [Abstract] [Full Text] [PDF]

				M. S. Deloire, T. Touil, B. Brochet, V. Dousset, J.-M. Caille, and K. G Petry Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment Multiple Sclerosis, October 1, 2004; 10(5): 540 - 548. [Abstract] [PDF]

				A. T. Reder and J. J. Oger Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis Neurology, June 8, 2004; 62(11): 1922 - 1923. [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help